Ongoing Clinical Trials

Indication
Institution
Department
Principal Investigator
Protocol Title
TMU-JIRB No. Protocol Title Indication Institution Department Principal Investigator Contact
N202305080 ARTEMIS: Ravulizumab to Protect Patients with Chronic Kidney Disease (CKD) from Cardiac Surgery Associated Acute Kidney Injury (CSA AKI) and Subsequent Major Adverse Kidney Events (MAKE): A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study Chronic Kidney Disease WFH Cardiovascular Surgery Chun-Che Shih Sih-Chen Wang
0958131385
N202005024 Phase I/II, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Anti-tumor Efficacy of DZD9008 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with EGFR or HER2 mutation Lung Cancer WFH Hematology And Oncology Chia-Lun Chang Wei-Ling Yang
0229307930 #2556
N202301037 A Phase I, Open-label, Dose-escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Modified Salmonella Typhimurium SGN1 Administered via Intratumoral Injection in Patients with Advanced Solid Tumors Solid tumors WFH Hematology And Oncology Chia-Lun Chang Wei-Ling Zhou
0914019869
N202306066 A Randomized, Double blind Study Evaluating Pharmacokinetic Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Resected Stage III or Stage IV Melanoma Subjects in the Adjuvant Setting Melanoma WFH Hematology And Oncology Chia-Lun Chang Wei-Ling Zhou
0914019869
N202204010 A randomized, evaluator-blinded, controlled study to evaluate the safety and clinical performance of OIF/β-TCP in patients with open tibial fractures in need of bone grafting. Tibial fracture WFH Orthopedics Kuo Yi-Jie Hsiu-Chen Chang
0229307930 #2550
N202107070 A Prospective, Randomized, Open-Label, Add-On, Parallel Control Study to Investigate Safety and Efficacy of the cold water extract of Arthrospira maxima in Patients with Ambulatory Mild and Moderated Disease COVID-19 COVID-19 WFH Infection Fu-Lun Chen Hsiu-Yen Wang
0229307930 #2544
N202301029 A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of EDP-938 in Non-hospitalized Adults with Acute Respiratory Syncytial Virus Infection who are at High Risk for Complications Acute Respiratory Syncytial Virus Infection WFH Infection Tsong-Yih Ou Hsiu-Chen Chang
0229307930 #2550
N202302038 A Phase III, Multicentre, Randomised, Double blind, Parallel group, Placebo controlled Study to Evaluate the Efficacy and Safety of Tozorakimab (MEDI3506) in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen (TILIA). Viral Lung Infection Requiring Supplemental Oxygen (TILIA) WFH Infection Tsong-Yih Ou Hsiu-Chen Chang
0229307930 #2550
N202207016 A Multicentre, Randomized, Double-blind Study to Evaluate and Compare the Efficacy and Safety of 8-week Treatment with Azilsartan Medoxomil and Amlodipine Besylate Combined and Alone in Mild-to-moderate Essential Hypertensive Subjects High Blood Pressure/Hypertension WFH Cardiology Ming-Hsiung Hsieh Sih-Chen Wang
0958131385
N202203001 A pivotal Phase 3, multicenter, randomized, double-blind, placebo-controlled study of the efficacy and safety of DMX-200 in patients with focal segmental glomerulosclerosis (FSGS) who are receiving an angiotensin II receptor blocker (ARB) Focal segmental glomerulosclerosis (FSGS) SHH Nephrology Mai-Szu Wu Ya-Chun Chang
0976909019
1 2 3 4 5 6 7 8 9 10 11 12 13 / 13

TOP